Figure 1.
![Figure 1. Catheter-directed thrombolysis reduces moderate/severe postthrombotic syndrome in IFDVT. This forest plot was derived from a meta-analysis of all patients in the CaVenT trial and the subgroup of patients with IFDVT in the ATTRACT trial using a fixed-effect model (Review Manager, version 5.3; Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).22,23,25 The outcome of interest was long-term moderate/severe PTS, reported at 5 years in CaVenT and 2 years in ATTRACT. CDT and anticoagulation (AC) reduced the incidence of moderate to severe PTS in patients with IFDVT compared with AC alone (risk ratio, 0.61; 95% confidence interval [CI], 0.43-0.86, P = .005). M-H, Mantel-Haenszel.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/2/14/10.1182_bloodadvances.2018018622/3/advances018622f1.jpeg?Expires=1722429800&Signature=mUUbM3g-8zJJfwaJulrE5uHy271arEzYGSD1VJog2joxTL-qiBp6QuBJneVBNtvKE7qbjR4cr0mD~jjMV04MNbT535NAVBlLSW432egZrYoTor1N8VdW~lklstYlAT8jmQzI9mXz6sPj~7iTDR9GWZa4HeT4GlpcgPuco8wqfZBkx33nSfAcIRZy3KCNKMmcDmnbgklQsVlPRdZFqlIjLSN1nJMTadiKQiKXp9Dn5phhdLMqGFXHL2Czi5FcQ-NKMTHQ3YwFDo4LNJ4upJ4hkeGQu8cVYNEgLGN9heA7tZXHIjJwoTPaIPJwQLIOnMtv4eCVJjvWPNgtTeF8u-U31g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Catheter-directed thrombolysis reduces moderate/severe postthrombotic syndrome in IFDVT. This forest plot was derived from a meta-analysis of all patients in the CaVenT trial and the subgroup of patients with IFDVT in the ATTRACT trial using a fixed-effect model (Review Manager, version 5.3; Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).22,23,25 The outcome of interest was long-term moderate/severe PTS, reported at 5 years in CaVenT and 2 years in ATTRACT. CDT and anticoagulation (AC) reduced the incidence of moderate to severe PTS in patients with IFDVT compared with AC alone (risk ratio, 0.61; 95% confidence interval [CI], 0.43-0.86, P = .005). M-H, Mantel-Haenszel.
